We are live on ! Find out more
LLY icon

Eli Lilly

1,005 hedge funds and large institutions have $42.1B invested in Eli Lilly in 2013 Q4 according to their latest regulatory filings, with 112 funds opening new positions, 341 increasing their positions, 406 reducing their positions, and 69 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more first-time investments, than exits

New positions opened: 112 | Existing positions closed: 69

11% more call options, than puts

Call options by funds: $460M | Put options by funds: $416M

3% more funds holding

Funds holding: 9741,005 (+31)

2% more capital invested

Capital invested by funds: $41.1B → $42.1B (+$950M)

0.62% more ownership

Funds ownership: 72.69%73.31% (+0.62%)

16% less repeat investments, than reductions

Existing positions increased: 341 | Existing positions reduced: 406

17% less funds holding in top 10

Funds holding in top 10: 2319 (-4)

Holders
1,005
Holders Change
+31
Holders Change %
+3.18%
% of All Funds
29.16%
Holding in Top 10
19
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-17.39%
% of All Funds
0.55%
New
112
Increased
341
Reduced
406
Closed
69
Calls
$460M
Puts
$416M
Net Calls
+$44.3M
Net Calls Change
-$109M
Name Holding Trade Value Shares
Change
Change in
Stake
MJP
851
Michael J. Puzo
$248K
SL
852
Summitry LLC
California
$247K
NPPM
853
North Point Portfolio Managers
Ohio
$246K -$147K -2,935 -38%
SWA
854
SFMG Wealth Advisors
Texas
$245K -$16K -320 -6%
MCC
855
Mid Continent Capital
Illinois
$245K
NME
856
Notis-McConarty Edward
$244K +$240K +4,786 New
TFF
857
Timothy F. Fidgeon
$243K
DVM
858
Dreman Value Management
Florida
$243K +$23.5K +470 +11%
GIP
859
Greatmark Investment Partners
Georgia
$242K -$50.1K -1,000 -17%
AT
860
Acadia Trust
Maine
$241K
BRA
861
Bender Robert & Associates
California
$241K +$4.76K +95 +2%
BCB
862
Brian C. Broderick
$240K
NIM
863
Nexus Investment Management
Ontario, Canada
$240K
EWM
864
Evercore Wealth Management
New York
$240K +$50.1K +1,000 +27%
SSG
865
Summit Securities Group
New York
$240K +$60.1K +1,200 +34%
HCM
866
Hollencrest Capital Management
California
$238K +$233K +4,660 New
TC
867
TFS Capital
Pennsylvania
$237K +$233K +4,646 New
PCA
868
Peddock Capital Advisors
Massachusetts
$235K +$230K +4,600 New
VIA
869
Vantage Investment Advisors
Pennsylvania
$234K +$230K +4,602 New
S
870
SignatureFD
Georgia
$233K +$54.1K +1,080 +31%
AIM
871
Acropolis Investment Management
Missouri
$231K -$131K -2,625 -37%
WSTAM
872
Wilbanks Smith & Thomas Asset Management
Virginia
$230K +$4.76K +95 +2%
UGIF
873
US Global Investors Funds
Maine
$230K +$225K +4,500 New
USGIU
874
U.S. Global Investors (USGI)
Texas
$230K +$225K +4,500 New
VAM
875
Verity Asset Management
North Carolina
$228K +$224K +4,469 New

LLY Hedge Fund Activity: Q4 2013 in Review

1,005 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q4 2013, worth a combined $42.1B — up 2.3% from $41.1B a quarter earlier.

Buyers outnumbered sellers: 112 funds opened new LLY positions and 69 closed out — a net gain of 43 holders — while 341 added to existing stakes and 406 trimmed.

The largest buyer was Franklin Resources, adding an estimated $711M. The largest seller was Fidelity Investments, cutting an estimated $141M.

  • 1,005 institutional investors held Eli Lilly (LLY) as of Q4 2013, up from 974 in Q3 2013.
  • Funds reported $42.1B of Eli Lilly stock for Q4 2013, up 2.3% quarter-over-quarter.
  • 112 funds opened new Eli Lilly positions in Q4 2013 and 69 closed out, a net change of +43 holders.
  • The largest Eli Lilly buyer in Q4 2013 was Franklin Resources, an estimated $711M added.
  • The largest Eli Lilly seller in Q4 2013 was Fidelity Investments, an estimated $141M sold.

Based on aggregated 13F filings for Q4 2013.